Table 2.

Cox regression analysis of SNF5 expression and other clinicopathologic characteristics on 5-y survival of 88 primary melanoma patients

Variable*Overall survivalDisease-specific survival
Relative risk (95% CI)PRelative risk (95% CI)P
SNF55.145 (1.48-17.89)0.0104.637 (1.15-18.63)0.031
Age0.775 (0.28-2.12)0.6200.870 (0.29-2.57)0.802
Gender3.215 (1.29-8.00)0.0122.804 (1.06-7.44)0.038
Thickness0.296 (0.09-0.94)0.0390.233 (0.06-0.87)0.030
Ulceration0.293 (0.10-0.85)0.0240.243 (0.08-0.76)0.015
Location0.705 (0.26-1.93)0.4970.601 (0.21-1.71)0.340
Subtype0.476 (0.13-1.81)0.2760.531 (0.14-2.07)0.362
  • *Coding of variables: SNF5 was coded as 1 (negative), and 2 (positive). Age was coded as 1 (≤57 y), and 2 (>57 y). Gender was coded as 1 (female) and 2 (male). Thickness was coded as 1 (≤2 mm), and 2 (>2 mm). Ulceration was coded as 1 (absent) and 2 (present). Location was coded as 1 (head and neck), and 2 (others). Subtype was coded as 1 (nodular) and 2 (others).